SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

IMS & AGM

18 Apr 2013 07:00

RNS Number : 6284C
Devro PLC
18 April 2013
 



For immediate release 18 April 2013

 

 

Devro plc

(the "Group")

 

Interim Management Statement and Annual General Meeting

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today issues the following Interim Management Statement for the period from 1 January 2013 to date, ahead of its Annual General Meeting to be held at 11.00am. Steve Hannam, Chairman of Devro, will make the following statement on current trading.

 

"Devro's global sales have continued to grow during the period. This has been underpinned by good growth in much of Europe and North America, offset by a slower start in the UK and Australia. Select has begun the year well, particularly in Germany where it continues to make good progress.

 

"The major capital investment programme in the Czech Republic is proceeding as planned, with significant additional volume scheduled to come on stream in the second half of this year in order to support further growth in 2014.

 

"As announced at the time of the 2012 preliminary results, we have now implemented the planned price increases we referred to at that time. Input costs have also risen broadly in line with our expectations.

 

"Manufacturing performance, however, has been held back by lower yields, particularly in the USA, which has restricted product available for sale and impacted unit costs.

 

"We remain confident that the Group will meet the board's expectations for the full year. Whilst profits for the first quarter of the year are below the corresponding period in 2012 due to lower production yields, remedial action has already been taken and, with the benefits of recent price rises, additional volume from extra capacity and a focus on improving production processes, we do expect stronger performance as the year progresses.

 

"Net debt and cash flow are both as expected and the financial position of Devro continues to be strong."

 

Peter Page, Chief Executive, commented "Sales continue to grow in volume and value terms across the Group and our investments in people and infrastructure will ensure we have the necessary capability to take advantage of the significant opportunities that exist."

 

ENDS

 

For further information, please contact:

 

Devro plc

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

 

 

Tel No: 0207 182 4960

 

Buchanan

Diane Stewart/ Carrie Clement/

Charles Ryland

 

 

 

Tel No: 020 7466 5000/0131 226 6150

www.buchanan.uk.com

 

Notes to Editors

 

FTSE 250 listed Devro is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from 5 manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £241.1 million and profit before tax (excluding pension interest) of £42.2 million for the year ended 31 December 2012. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 

Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUWUCUPWGBM
Date   Source Headline
24th Mar 20174:00 pmRNS2016 Annual Report
15th Mar 20175:14 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSNotification of Board changes
6th Mar 20177:00 amRNSFinal Results
21st Feb 20172:43 pmRNSHolding(s) in Company
25th Jan 20174:36 pmRNSHolding(s) in Company
11th Jan 20177:00 amRNSYear End Trading Update
21st Dec 20167:00 amRNSAppointment of Non-Executive Director
8th Dec 20164:52 pmRNSDirector/PDMR Shareholding
8th Dec 20164:15 pmRNSDirector/PDMR Shareholding
7th Dec 20164:32 pmRNSDirector/PDMR Shareholding
25th Nov 20163:01 pmRNSDirector/PDMR Shareholding
24th Nov 20163:14 pmRNSBlock listing Interim Review
23rd Nov 20161:32 pmRNSDirector/PDMR Shareholding
14th Nov 201611:36 amRNSDirector/PDMR Shareholding
10th Nov 20164:12 pmRNSDirector/PDMR Shareholding
10th Nov 20164:07 pmRNSDirector/PDMR Shareholding
10th Nov 201610:51 amRNSDirector/PDMR Shareholding
10th Nov 20167:00 amRNSTrading Update
21st Sep 20165:05 pmRNSHolding(s) in Company
18th Aug 20162:24 pmRNSDirector/PDMR Shareholding
18th Aug 20162:23 pmRNSDirector/PDMR Shareholding
11th Aug 201610:41 amRNSHolding(s) in Company
8th Aug 20162:15 pmRNSDirector/PDMR Shareholding
3rd Aug 20167:00 amRNSHalf-year Report
21st Jul 20163:53 pmRNSHolding(s) in Company
30th Jun 20167:00 amRNSTotal Voting Rights and Share Capital
23rd Jun 20163:16 pmRNSDirector/PDMR Shareholding
10th Jun 201610:18 amRNSHolding(s) in Company
25th May 20165:38 pmRNSHolding(s) in Company
24th May 201611:53 amRNSBlock listing Interim Review
23rd May 20163:33 pmRNSDirector/PDMR Shareholding
13th May 20163:33 pmRNSDirector Declaration
5th May 20164:23 pmRNSHolding(s) in Company
28th Apr 20163:54 pmRNSDirector/PDMR Shareholding
27th Apr 20164:45 pmRNSResults of Annual General Meeting
27th Apr 20167:00 amRNSTrading Update
8th Apr 20163:33 pmRNSNotification of Transactions of Directors
30th Mar 20167:00 amRNSAnnual Financial Report
29th Mar 201612:35 pmRNSFurther re: Group Finance Director Retirement
23rd Mar 201612:52 pmRNSNotification of Transactions of Directors
1st Mar 20167:00 amRNSFinal Results
17th Feb 201610:13 amRNSHolding(s) in Company
9th Feb 201612:56 pmRNSHolding(s) in Company
9th Dec 20157:00 amRNSGroup Finance Director
27th Nov 20154:30 pmRNSNotification of Transactions of Directors
24th Nov 20158:23 amRNSBlock Listing Six Monthly Return
17th Nov 20157:01 amRNSGroup Finance Director Retirement
17th Nov 20157:00 amRNSTrading update
21st Oct 20157:00 amRNSNotice of trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.